See also this year's filing and all EDGAR filings for this company.
PDF Report 0001685071_2018_Dova_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001685071, Dova Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 96,317,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 62,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 35,197,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,499,000 |
| 9 | ResearchAndDevelopmentExpense | 14,710,000 |
| 10 | remainder_Expenses | 1,000,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -746,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 96,379,000 |
| 1 | Liabilities | 35,197,000 |
| 2 | Expenses | 29,209,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 61,182,000 |
| 5 | NetIncome | -29,955,000 |
| 6 | ComprehensiveNetIncome | -29,955,000 |
| 7 | BaseVar | 80,765,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.57 |
| 9 | EconomicCapitalRatio | 2.73 |
Edgar->Model Mapping
Feature Distribution
